000 01141 a2200301 4500
005 20250515015444.0
264 0 _c20060621
008 200606s 0 0 eng d
022 _a1472-4472
040 _aNLM
_beng
_cNLM
100 1 _aKoelle, David M
245 0 0 _aVaccines for herpes simplex virus infections.
_h[electronic resource]
260 _bCurrent opinion in investigational drugs (London, England : 2000)
_cFeb 2006
300 _a136-41 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aClinical Trials as Topic
650 0 4 _aHerpes Simplex
_ximmunology
650 0 4 _aHerpes Simplex Virus Vaccines
_xtherapeutic use
650 0 4 _aHerpesvirus 1, Human
_ximmunology
650 0 4 _aHerpesvirus 2, Human
_ximmunology
650 0 4 _aHumans
650 0 4 _aVaccines, Attenuated
_xtherapeutic use
650 0 4 _aVaccines, Inactivated
_xtherapeutic use
650 0 4 _aVaccines, Subunit
_xtherapeutic use
773 0 _tCurrent opinion in investigational drugs (London, England : 2000)
_gvol. 7
_gno. 2
_gp. 136-41
999 _c16110205
_d16110205